AFM
VYNT

Anson Funds Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Anson Funds Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,811
Closed -$476K – 103
2016
Q3 		$476K Buy
+1,811
New +$555K 0.1% 48

Other funds holding VYNT

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $169M AUM 12.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Anson Funds Management's VYNT Position: Q4 2016 in Review

Anson Funds Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2016, closing a stake of 1,811 shares — an estimated $476K sold.

Anson Funds Management first reported a position in VYNT in Q3 2016 and held it in 1 quarter. The position peaked at $476K in Q3 2016. 29 funds tracked by Wall St. Rank hold VYNT as of Q4 2016.

  • Anson Funds Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Anson Funds Management sold 1,811 Vyant Bio, Inc. Common Stock shares in Q4 2016, an estimated $476K.
  • Anson Funds Management first reported a position in Vyant Bio, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
  • Anson Funds Management's Vyant Bio, Inc. Common Stock position peaked at $476K in Q3 2016.
  • 29 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2016.

Based on Anson Funds Management's 13F filing for Q4 2016, filed 14 Feb 2017.